Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

fexofenadine-pseudoephedrine

fexofenadine-pseudoephedrine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Allegra-D 12 Hour TABLET, EXTENDED RELEASE, ORAL 60 mg-120 mg    
Allegra-D 24 Hour TABLET, EXTENDED RELEASE, ORAL 180 mg-240 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

fexofenadine-pseudoephedrine (Allegra-D 12 Hour)

  • 60 mg-120 mg extended release tablet oral Q12 hours

loratadine-pseudoephedrine (Claritin-D 24 Hour)

  • 10 mg-240 mg extended release tablet oral Q24 hours

fexofenadine-pseudoephedrine (Allegra-D 24 Hour)

  • 180 mg-240 mg extended release tablet oral Q24 hours

loratadine-pseudoephedrine (Claritin-D 24 Hour)

  • 10 mg-240 mg extended release tablet oral Q24 hours
Last updated: Dec. 21, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved